Developmental basis for filamin-A-associated myxomatous mitral valve disease. - Wikidata - awgldk - TriplyDB

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

http://www.wikidata.org/entity/Q34640929

about

Mitral valve disease--morphology and mechanisms.Genetics of valvular heart disease klf2a couples mechanotransduction and zebrafish valve morphogenesis through fibronectin synthesis.Mutations in DCHS1 cause mitral valve prolapse Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation.Increased Infiltration of Extra-Cardiac Cells in Myxomatous Valve Disease.Dynamic Heterogeneity of the Heart Valve Interstitial Cell Population in Mitral Valve Health and Disease MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions.Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities Genetic association analyses highlight biological pathways underlying mitral valve prolapse.Distinct signaling pathways activated by "extracellular" and "intracellular" serotonin in heart valve development and disease.Effect of altered haemodynamics on the developing mitral valve in chick embryonic heart.Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.Mitral Valve Prolapse: Multimodality Imaging and Genetic Insights.New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study.Longitudinal Echocardiographic Evaluation of an Unusual Presentation of X-Linked Myxomatous Valvular Dystrophy Caused by Filamin A Mutation.Genetics of syndromic and non-syndromic mitral valve prolapse.Investigation of the Matrix Metalloproteinase-2 Gene in Patients with Non-Syndromic Mitral Valve Prolapse.Filamin A mitral valve disease: prolapse, dystrophy, or dysplasia?

P2860

Q26781699-DB87FDF2-3DC6-4EE0-AFC0-574D8A3D5FDB Q27014805-8A406170-6620-4EF8-8413-51594D49E733 Q27316170-52AD8170-4CEE-40B2-9A80-F1834CD016C9 Q28116846-06D3CDDB-F7FA-4747-B0BA-94A6AB679973 Q30572197-32D9495E-B42E-4803-97FE-A11EB4C5B05A Q36155598-261F21C4-40F9-4176-8C97-27202EAC80BD Q36222898-05B6C38B-44DC-401A-ACAB-93EC66EC8233 Q36303009-719AAC73-8956-4BD9-9132-16DE0E43B96F Q36498609-0D81FFE6-66EB-4B34-AD13-212CDFAF4EB2 Q36638702-BF540C9D-EB50-4B87-9897-EF29146C449E Q38100690-3F336E98-2005-46D2-9927-69506811D872 Q38747621-A9AB49B7-908E-4394-AF56-7C893215A438 Q39030652-BB37FEDF-7C28-40E8-BEFF-19BCCA845CC0 Q46290208-F04B93B5-E0CA-4F54-A6C2-718D828398D7 Q46808997-EC87B1A1-A317-41B1-9F0C-A0DF07E0ACC7 Q47449759-79403376-183A-4FCA-A77C-12F1C9DF702E Q47722741-EF02787D-36A2-4505-8B7B-16A56C8EDC57 Q49369869-2BED6337-E7D9-472D-94C5-65EC3D6CF816 Q50080794-BED90677-2173-4CB0-A213-756F30B00A4D

P2860

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

http://www.wikidata.org/entity/Q34640929

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@ast

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@en

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@nl

type

label

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@ast

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@en

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@nl

prefLabel

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@ast

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@en

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@nl

P1433

Q34640929-7AFEE034-5EB6-4D7F-B2B7-232577431CAA

P1476

Q34640929-FD00A4E0-3693-4222-AD0E-029E41855F11

P2093

Q34640929-1CAC2635-6D70-4DFD-9C68-7E6D9CCF6362

Q34640929-1F0EA810-A188-4B61-AA32-035583F64FF2

Q34640929-30CA0A6A-CFC3-4F2F-AE13-CDEAE6273D32

Q34640929-36031284-B81C-4916-B72B-2C125D3DA415

Q34640929-3E4648C9-CA82-4A47-82B8-B143D504A452

Q34640929-4219CB29-6AC7-4BB2-AA31-13BE10DD4453

Q34640929-5FE145D4-DD1D-485A-80BE-F9164F1FC015

Q34640929-60458D84-F22C-44F0-90A9-25F05D71D977

Q34640929-6BFB1E83-670C-48BE-9810-A5F54273BB4D

Q34640929-701E3980-1431-49FC-8554-19EAEFA61192

P2860

Q34640929-0A19C6E4-66B8-4D2B-8B87-9C0A1EDCBC05

Q34640929-0A8438B7-BB3A-4343-A6CA-25E90CA32217

Q34640929-12FB91E3-156F-4967-989F-38D818580EED

Q34640929-27CA44D4-74AC-430D-9A2A-E5154A7A8BAF

Q34640929-2EC217E9-687A-43C0-B7D8-2708E3A04456

Q34640929-30F88E18-97C6-4A38-8EA8-1E18F07C1A89

Q34640929-3E76D068-C236-47AC-B313-2F37DDA5A9CD

Q34640929-3F693BE4-7A40-42C9-99B3-ED62EA9270D5

Q34640929-51E3B352-BA75-4791-87E2-E462EA48FE1A

Q34640929-5274CBA8-22DE-4183-9A2B-82E9F67937BD

P304

Q34640929-9E7E17FC-F11D-4562-8629-C01F4DADFBD0

P31

Q34640929-28CFA24D-4DCA-425C-8C79-9CD99B1CA95A

P356

Q34640929-6048DCF2-5E9E-4C0A-9B06-8C132BF03356

P433

Q34640929-8B44186D-D9CD-4CD5-A061-EF5BB44C1F4E

P478

Q34640929-E9248EF9-DAD0-4527-A9BC-BC744B23FEA9

P50

Q34640929-2F841D8A-D5B9-455F-A862-84B7B909ABA4

P577

Q34640929-BDB3928B-C155-4B39-B99D-8468B52F1F7F

P5875

Q34640929-2F0AB41F-C589-4481-8549-EBBF85824DC4

P698

Q34640929-BEF747AD-E3C4-4603-903B-E1B4D86D8B16

P932

Q34640929-C69C7FBC-1A42-477A-8570-FFE5682CD3FF

P356

P1433

Cardiovascular Research

P1476

Developmental basis for filamin-A-associated myxomatous mitral valve disease.

@en

P2093

Andy Wessels

http://www.w3.org/2001/XMLSchema#string

Annemarieke de Vlaming

http://www.w3.org/2001/XMLSchema#string

Bin Zhou

http://www.w3.org/2001/XMLSchema#string

Brett S Harris

http://www.w3.org/2001/XMLSchema#string

Christopher Walsh

http://www.w3.org/2001/XMLSchema#string

Jean Merot

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Schott

http://www.w3.org/2001/XMLSchema#string

Katherine Williams

http://www.w3.org/2001/XMLSchema#string

Kimberly Sauls

http://www.w3.org/2001/XMLSchema#string

Luigi Michele Pavone

http://www.w3.org/2001/XMLSchema#string

P2860

Serotonylation of vascular proteins important to contraction

Filamin A regulates cell spreading and survival via beta1 integrins

Integrins: bidirectional, allosteric signaling machines

Filamins as integrators of cell mechanics and signalling

Valvular heart disease associated with fenfluramine-phentermine

5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats

Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis

Developmental effects of SSRIs: lessons learned from animal studies.

Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis.

P304

109-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVS238

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Jacques Schott

P577

2012-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230586085

http://www.w3.org/2001/XMLSchema#string

P698

22843703

http://www.w3.org/2001/XMLSchema#string

P932

3444235

http://www.w3.org/2001/XMLSchema#string